|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.36 SEK | +0.56% |
|
+8.76% | +10.09% |
Spago Nanomedical AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 1.2 million. Revenue was SEK 5.93 million.
Net loss was SEK 42.22 million. Basic loss per share from continuing operations was SEK 0.43.
| 1st Jan change | Capi. | |
|---|---|---|
| +10.09% | 7.38M | |
| -20.45% | 10.82B | |
| +43.17% | 3.25B | |
| -35.86% | 2.11B | |
| -17.21% | 2.08B | |
| -29.81% | 1.48B | |
| +17.56% | 1.02B | |
| -4.37% | 733M | |
| -37.00% | 391M | |
| -46.94% | 377M |
SPAGO NANOMEDICAL AB 
